Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network

The investments, including opening of a second national distribution center, support a more resilient and efficient pharmaceutical supply chain CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Cencora, a global pharmaceutical solutions company, today announced plans to invest $1 billion through 2030 to bolster and expand its pharmaceutical distribution network in the United States. The investments — headlined by the opening … [Read more…]

Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering

PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced the pricing of its upsized offering of $350.0 million aggregate principal amount of 0% convertible senior notes due 2033 (the “notes”) in a private offering (the “convertible notes offering”) to persons reasonably believed to be qualified institutional buyers … [Read more…]

Galderma Receives U.S. FDA Approval for Restylane® Lyft™ for the Enhancement of the Chin Profile

This approval is based on results showing the safety and effectiveness of Restylane Lyft in enhancing the chin profile, with high patient satisfaction and long-lasting results1,2 Restylane Lyft is the only hyaluronic acid (HA) injectable approved to treat the midface, facial folds and wrinkles, back of hands and the chin, with consistent results observed across … [Read more…]

VSAVA and NEL Animal Medical Foundation Partner to Introduce Vietnam’s First Specialized Veterinary Cardiology Course

A gateway for cooperation to advance Asian veterinary medicine Exchange of expertise in internal medicine, diagnostic imaging, and practical training with participation from Vietnamese and Korean experts HO CHI MINH CITY, Vietnam–(BUSINESS WIRE)–#AnimalHealth–The Vietnam Small Animal Veterinary Association (VSAVA) and NEL Animal Medical Foundation (NEL) have taken a significant first step in veterinary exchange between … [Read more…]

Dentalcorp Announces Receipt of Interim Order and Update Regarding Proposed Acquisition by Investment Funds Affiliated with GTCR

The Supreme Court of British Columbia has granted Dentalcorp an interim order in connection with the previously announced Arrangement pursuant to which shareholders are entitled to receive C$11.00 per share, representing a 33% premium to the 20-day VWAP of Dentalcorp’s shares on the TSX as of the day prior to the announcement of the Arrangement … [Read more…]

Catalent’s SMARTag® ADC Pipeline and New Enhanced Conjugates Offering Featured at 16th World ADC San Diego

Presented preclinical efficacy and tolerability data for CAT-09-833, a SMARTag® ADC targeting MUC1 featuring a novel, tumor-selective antibody Introduced SMARTag® Enhanced Conjugates, a new class of ADCs, with innovative cytotoxic and non-cytotoxic payload combinations on a single antibody designed to benefit patients by amplifying efficacy without compromising safety TAMPA, Fla.–(BUSINESS WIRE)–Catalent, Inc., a leading global … [Read more…]

Dren Bio Receives Prestigious 2025 Prix Galien USA Award for Best Biotech Startup

– Selected by a Distinguished Jury of Global Biopharma Leaders for Dren Bio’s Outstanding Innovation, Impact, and Scientific Excellence – SAN CARLOS, Calif.–(BUSINESS WIRE)–Dren Bio, a privately held, clinical-stage biotechnology company developing therapeutics for cancer, autoimmune, and other serious diseases, announced today that it received the 2025 Prix Galien USA Award for “Best Startup” by … [Read more…]

Canary Advisors Launches Canary Concierge, a Patient-Focused Clinical Trial Travel and Lodging Solution

New endeavor focuses on a positive patient and caregiver experience from start to finish Co-founders bring more than 15 years of combined experience participating in clinical trials and know the importance of on-demand, high-touch support DURHAM, N.C.–(BUSINESS WIRE)–#biotech—Canary Advisors, an industry leader in patient engagement, today announced the launch of Canary Concierge, a personalized clinical … [Read more…]

Zoetis Announces Third Quarter 2025 Results

Reports Revenue of $2.4 Billion, Growing 1%, and Net Income of $721 Million, or $1.63 per Diluted Share, Increasing 6% and 9%, Respectively, on a Reported Basis for Third Quarter 2025 Delivers 4% Organic Operational Growth in Revenue and 9% Organic Operational Growth in Adjusted Net Income for Third Quarter 2025 Reports Adjusted Net Income … [Read more…]

Tulyp Medical Emerges From Sofinnova’s Medtech Accelerator and Announces FDA Submission Following Initial First-in-Human Use

Company unveils patented technology designed to help maintain healthy blood flow during vascular procedures Backed by Sofinnova MD Start and led by experienced medtech entrepreneurs and cardiologists PARIS–(BUSINESS WIRE)–Tulyp Medical, a Paris-based startup developing a medical device for intelligent pressure-driven perfusion, emerged from stealth and announced it has submitted its 510(k) application to the U.S. … [Read more…]